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Glycoprotein Composition of Psoriatic Epidermis in Relation to Growth 
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The composition of isolated ["H]-fucose- and ["H]-glu-
cos amine-labeled glycopeptides from psoriatic lesion, 
psoriatic uninvolved, regenerating-normal, and normal 
epidermis (subdivided into basal and differentiated cells) 
has been analyzed according to molecular weight and 
affinity to concanavalin A. Basal cells from normal skin 
have a higher sialic acid content of their "biantennary" 
fucose-labeled glycoprotein!'; than differ entiated cells . 
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Fucose-labeled glycoproteins from regenerating norma l 
skin show an increased molecular weight of their car-
bohydrate moieties which precedes entrance of the cell 
into S-phase. In psoriatic uninvolved skin, glycoproteins 
with more highly branched carbohydrate structures are 
present in reduced quantity. The previously reported 
increase in percentage of high-molecular-weight fucose-
labeled glycopeptides for psoriatic lesions appears to be 
specific in that its composition cannot be explained in 
terms of an increased growth fraction. 
Striking abnormalities have been described in the molecular 
weight distribution of CH]-fucose-Iabeled glycopeptides derived 
from psoriatic keratinocytes [1]. An increased constant for the 
association between the fucose-specific lectin, Uiex europeus 
agglu tinin, and isolated intact keratinocytes from psoriatic le-
sions [2] indicates that this abnormality involves the cell surface 
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glycoprotein. Since th e latter molecules include hormone recep -
tors [3- 5] , it is clear t hat a direct etiologic link with the loss of 
growth control of psoriatic epidermis is feasible . 
In this paper we examine t wo alternative h ypotheses, namely 
tha t the observed abnormali ties could be secondary eith er to 
a n alteration of the proportion of cells in th e proliferative pool 
or to a higher cell tW'nover ("hyperplastic state" [6]) . The 
form er possibility has been investigated by the a nalysis of basal 
cell-enrich ed a nd spinous cell-enriched preparations from 
h eal t hy huma n epidermis, a nd the latter by comparison with 
normal epidermis during t h e regenera tive response to tape 
stripping. 
MATERIALS AND METHODS 
Materials 
L-[6-·1H]-Fucose (17.1 Cilmmol) and D-[6-"H]-glucosamine hydro-
chloride (38 Ci/ mmol) were obtained from the Hadiochemical Centre, 
Amersham. Concanavalin A(Con-A) -Sepharose 4B was obtained from 
Pharmacia, Sweden, a -methyl-D-mannoside (a-MM) and neUl'amini-
dase (from clostridium perfringens, type VI) from Sigma (St. Louis, 
Missouri) . All other chemicals were as described previously [1]. 
S I/in Samples 
Control specimens (1 cm> x 0.2 mm) were obtained from healthy 
volunteers (aged 18-46). Samples of lesion (1 cm" x 0.3 mm) and 
uninvolved skin (1 cm' X 0.2 mm) w~re taken from psoriatic patients 
with chronic, stable plaques and who had used no local or systemic 
therapy for at least 2 weeks prior to biopsy [7). Further, experiments 
were carried out in which the st1'atum corneum was "stripped" by 
repeated application of tape (Tesaftlm, Beiersdorf b.v., Almere, The 
Netherlands) to t he skin of healthy volunteers [2). Following about 15 . 
consecutive applica tions, the underlying epidermis became red and 
moist and no flll'th er corneocytes were seen adhering to the tape. 
Biopsies (1 cm' x 0.2 mm) of the stripped areas were obtained at 24 , 
48, and 72 hr, as described for the control specimens [7). 
Preparation of Cell Suspensions 
Suspensions of isolated keratinocytes were prepared as described by 
Gommans et al [7). Briefly, the biopsy was floated, dermal face down, 
in a plastic P etri dish conta ining a solution of trypsin (0.25 mg/ml) and 
dithioerythritol (3 mg/ ml) in 10 ml of phosphate- buffered saline, pH 
7.4. After 30 min at 37°C, the in tact specimen was t ransferred to a 
second Petri dish containing 2 ml of TC 199 medium supplemented 
with 20% calf serum and antibiotics. The dermis was peeled from the 
epidermis and after transfer of the content of the Petri dish to a tube, 
cells were freed by gently agita ting (Vortex mixer) for I min. After 
removal of the horny layer and dermis, the remaining suspension was 
incubated with ribonuclease and filtered through a Phywe Korbfilter. 
The cells were pelleted by centrifugation and washed 3 t imes with TC 
199 medium supplemented with 20% calf serum and antibiotics. 
For preparation of basal ceLl- and spinous cell-enriched suspensions 
[2], the time of incubation with trypsin-dithioerythri tol in the above 
procedure was reduced to 15- 20 min. After separa tion of epidermis 
from dermis, an appreciable fraction of the epidermal keratinocytes 
remained adhered to the dermis, from which they could be fr eed after 
transfer of the dermis to a tube by vigorous agitation in medium 
contain ing 20% calf serum (basal cell-enriched suspension). The re-
maining content of the Petri dish (medium and the rest of the epider-
mis) was used for preparation of a spinous cell-enriched suspension as 
described for the total cell preparation. 
Labeling Procedure 
All cell suspensions were labeled for 22 hJ' wi th either ["H]-fucose or 
("H]-glucosamine (8). Briefly, the washed keratinocytes (usua lly 1-2 x 
10") were suspended in 0.5 ml T C 199 mediu m supplemented with 20% 
calf serum and containing 200 U/ ml penicillin and 100 ,ug/ ml strepto-
mycin sulfate. The appropriate radioactive sugar was added (10 !tCii 
mI) and the suspension was incubated at 37°C. After 22 hr, the cells 
were peLleted by centrifugation and washed 3 times with T C 199 
medium wi thou t serum. The washed cells were fina lly extracted 3 times 
with ice-cold trichloroacetic acid (TCA-insoluble sugar). 
Glycopeptide Preparation 
Glycopeptides were prepared as described ern'lier [I). Bljefly, the 
TCA-insoluble sugar was extracted with chloroform:methanol (2:1, vi 
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v) . The residue was dried at 60°C and digested with papain. The 
solubilized material contained the labeled glycopeptides. 
Gel Filtration 
In general, samples of 0.5 ml (- 10,000 dpm) were applied to a 
Sephadex G-50 column as described ern'lier [I). The column had been 
equilibrated with 0.2 M pyridine-acetate bu ffe r (pH 5.0) and elu tion was 
performed with the same buffer. The column dimensions were 2.5 x 32 
cm, the flow rate was 35 ml/hJ', and 2.25-ml fractions were collected. In 
aU experiments ultraviolet monitoring was used to establish t he position 
of added marker proteins and the breakdown products of papain 
interna lly present in the chromatographed sample [1). 
R adioactivity 
Radioactivity was determined by scin tillation cOlln ting as described 
previously [8]. 
DNA Content 
In the case of biopsies taken from health controls fo llowing tape 
stripping, a liquots of the keratinocyte suspensions were fLxed in ice-cold 
absolu te ethanol and the DNA distribution det.ermined using a flow 
cytometer [9). 
A ffinity Chromatography 
Labeled glycopeptides were fractionated on a column of Con-A-
Sephrn'ose 4B (0.9 X 7.5 cm) equilibrated with 0.015 M Tris-HCl pH 7.4 
as buffer. T his buffer contained MnCI., MgCt." CaCl., (ImM each), and 
1 M NaC \. Samples of 300 !t\ (about 5000 dpm) were applied to the 
column and subsequently elu ted with 15 ml bu ffer, 15 ml buffer with 
(Y- MM (5 mM), 15 ml buffer with a-MM (1 5 mM) , and 30 ml buffer with 
(v-MM (150 mM). T he flow rate was 30 ml/hr at 4°C. 
Neuraminidase Treatment of Glycopeptides 
Five hunc\J'ed microli ters of eluate from the Con-A-SephaJ'ose 4B 
column' was buffered with 100 ,ul 1 M pyridine-acetate buffer pH 5.0, 
and the mixture was incubated with 50 J.l I (0.5 U) neuraminidase for 48 
hr at 37°C to which 1 drop of toluene was added. 
RESULTS 
The molecula r weight distributions of eH]-fucose-labeled 
a nd CH]-glucosamine-Ia beled glycopeptides from basal cell-en-
rich ed a nd spinous cell-enrich ed pJ'eparations of normal huma n 
keratinocytes over 4 fractions (A-D) of decreasing molecular 
weigh t [1] a re given in Table I. It can be seen that th e glyco-
peptides from basal cell preparations sh ow a lower C / B ratio 
(i .e., high er molecular weigh t) t han spinous cell preparations 
(p < 0.02 andp < 0.05 for fu cose a nd glucosamine, respectively). 
The values obtained for t h e total keratinocyte population from 
epidermis fo llowing stripping (Table 1) do not differ s ignifi-
can tly from normal with t h e except ion of t h e fucose-labeled 
glycopeptides 241U' after stripping (p < 0.01). In absolute terms 
the shift in C/ B ratios, both for basal cell-enrich ed preparations 
and for stripped epidermis after 24 lu' (using fucose as precur-
sor), is mu ch less t han th at observed for psoriatic lesions. The 
per centages of cells in S-phase, as determined by fl ow cytom etry 
a re 3.9%, 11.2%, a nd 5.8% for specimens taken 24, 48, a nd 72 hI', 
r espectively, after stripping; for comparison, corrected control 
values of 1.8% a nd 8.9% have been found for normal skin a nd 
psoriatic lesion, r espectively [9,10]. 
Affinity chromatography of fu cose-labeled gJycopeptides on 
a column of Con-A-Sepharose reveals th at all r a dioactivity 
applied to t h e column can be recovered by using an £,Y-MM 
concentration of 15 mM for th e elu t ion of bound glycopeptides. 
For a ll specimens used, 70% of the total bound fucose-labeled 
glycopeptides could be e lu ted by using an (Y-MM con cen tration 
of 5 mM. Table II, th erefore, shows t h e per centage of m aterial 
t hat does not bind to Con-A. Preparations fro m psoriatic lesions 
show a dis tinctly higher percentage of la beled glycopeptides 
that do not bind to Con-A compar ed to normal (p < 0.01). 
Basal cell-enrich ed a nd spinous cell-enriched prepar ations do 
not differ significantly from each other. Following stripping, t h e 
48- lu' a nd 72-hr specimens gave normal values; at 24 hr the 
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TABLE 1. Sephadex C-50 chromatography of labeled g lycop eptides 
Fraction 
Sugar Specimen Ratio C/B 
A B C 0 
Fucose NB (6) 5.7 ± 0.5 27.5 ± Ll 59.1 ± 1.7 6.7 ± 0.3 2.2 ± 0.1 
ND (6) 4.1 ± 0.8 22.0 ± 1.4 66.4 ± 1.9 6.7 ± 1.5 3.0 ± 0.3 
NS24 (4) 6.5 ± 0.4 28.5 ± 1.3 57.5 ± 1.4 6.6 ± 0.8 2.0 ± 0.1 
NS48 (4) 6.5 ± 2.1 24.0 ± 3.9 54.8 ± 3.2 13.8 ± 4.9 2.5 ± 0.4 
NS72 (3) 6.1 ± 1.8 27.1 ± 3.4 60.8 ± 5.2 5.1 ± 0.8 2.4 ± 0.5 
N (7) 3.9 ± 0.6 23.8 ± 0.8 61.3 ± 1.8 10.1 ± 2.3 2.6 ± 0.1 
PL (5) 9.9 ± 2.4 30.1 ± 3.1 43.9 ± 4.1 13.9 ± 4.6 1.6 ± 0.2 
Glucosamine NB (6) I Ll ± 1.7 25.8 ± 0.8 52.6 ± 2.5 10.0 ± 1.1 2.0 ± 0.1 
ND (6) 12.1 ± 1.0 21.1 ± 0.8 51.2 ± 0.9 15.1 ± 0.9 2.4 ± 0.1 
NS24 (4) 13.4 ± 1.8 25.8 ± 1.9 48.9 ± 1.0 11.5 ± 1.5 2.0 ± 0.2 
NS48 (4) 9.1 ± 1.3 22.7 ± 3.0 51.4 ± 1.8 16.0 ± 2.3 2.4 ± 0.3 
NS72 (3) 12.7 ± 3.1 23.1 ± 1.0 50.6 ± 1.8 13.3 ± 0.8 2.2 ± 0.1 
N (7) 10.3 ± 1.6 21.7 ± 0.6 51.5 ± 1.2 16.2 ± 0.8 2.4 ± 0.1 
The percentage distribution of radioactivity into fractions A-D (see Fig 1) is given ± S.E.M. Numbers of specimens are in parentheses. N = 
normal epidermis; NB = basal cells from normal epidermis; ND = differentiated cells [Tom normal epidermis; NS24 (48, 72) = cells from stripped 
normal epidermis, biopsied after 24 (48,72) hI'; PL = psoriatic lesion. Values for Nand PL are from [1]. 
TABLE II. Concanavalin A chromatography of fu. cose- labeled g lycopeptides 
N (13) PU (II) PL (7) NB (5) NO (5) NS24 (6) NS48 (6) NS72 (5) 
42 ± 1 38 ± 2 62 ± 3 36 ± 1 40 ± 2 47 ± 2 40 ± 3 39 ± 2 
Values of material not bound by Con-A are given as percentages of total applied radioactivity ± S.E.M. PU = Psoriatic uninvolved epidermis; 
for other symbols see Table 1. Numbers of specimens are given in parentheses. Recovery = 95-100%. 
TABLE III. Sephadex C-50 chromatography of fu.cose- labeled 
glycopeptides fractionated by concanavalin A-Sepharose 
chromatography 
Fraction Ratio Specimen 
A B C 0 C/B 
CB-N 2.3 13.0 79.6 4.3 6.2 
-PU 2.7 10.7 78.3 7.7 7.3 
-PL 6.9 (4.1) 19.5 (16 .. 1) 67,4 (76.2) 4.7 (3.4) 3.5 (4.7) 
-NB 3..1 (2. 1) 19.1 (]1.0) 73.8 (83.3) 3.2 (3.1) 3.9 (7.6) 
-NO 1.9 (1.5) 12.7 (8.2) 82.8 (85.0) 1.9 (5.3) 6.5 (l0,4) 
CU-N 6.8 (7. 1) 43.9 (30.3) 37.1 (46.0) 12.0 (15.3) 0.8 0.5) 
-PU 3.3 (7.6) 33.5 (23.7) 48.7 (49.2) 13,4 (18.5) 1.5 (2.1) 
-PL 14.5 (8.0) 42. 1 (33A) 27.2 (37.5) 15.4 (20.8) 0.6 (J.l) 
-NB 8.6 44 .0 34 .2 12.2 0.8 
-ND 9.8 43.9 34.1 11.6 0.8 
The percentage distribution of radioactivity into fractions A-O (see Fig I) is 
given. Symbols are as in Table 1. Values for glycopeptides treated with neuramin-
idase before Sephadex G-50 chromatography are given in parentheses. 
difference was barely significant (p = 0.1). In absolu te terms all 
th ese preparations contain less unbound glycopeptides than 
psoriatic lesion (p = 0.01). 
Combining both chromatographic techniques it appears that 
for th e studied fucose-labeled glycopeptides (Table III) the 
Con -A:bound fractions are mainly eluted in the C fraction, 
while Con-A-unbound m aterial is distributed between the B 
and C fractions. It can be seen , as illustrated in Fig I, that basal 
cell-enriched and spinous cell-enriched preparations appeal' to 
differ from each other in th e molecular weight composition of 
th eir Con-A-bound glycopeptides. These differences can be 
reduced by pretreatment of glycopeptides with ne ul'aminidase 
(Table III). Although the Con-A-bound glycopeptides of pso-
riatic lesions resemble those from basal cell-enrich ed prepara-
tions, differences become apparent after neuraminidase treat-
ment. Con-A-bound glycopeptides from psoria tic uninvolved 
skin preparations give the same molecular weight distribution 
as normal epidermis. Gel filtration of Con-A-unbound glyco-
peptides shows similar elution profiles for basal cell-enrich ed 
and spinous cell-enriched preparations (Fig. l); the other sp ec-
imens show a decrease in percentage of high-molecular-weight 
glycopeptides in the order lesion > normal > uninvolved . Dif-
ferences among glycopeptides of these sp ecimens can, in gen-
18 
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FIG 1. Elution profiles of fu cose-labeled glycopeptides 0 11 Sephadex 
G-50 after preliminal'Y fract ionation on a Concanavalin A-Sepharose 
4B column. CB = Con A-bound fraction, CU = Con A-unbound fraction, 
NB = basal cells from normal epidermis, ND = differentiated cells from 
normal epidermis. For Subdivision into A-D see [1]. 
eral, be diminish ed but not removed by treatm ent with ne UT-
aminidase . 
DISCUSSION 
Differences found in the molecular weight composition be-
tween la beled glycopeptides isolated from basal and differe n-
tiated cells (Table I) appear to be confined to the composition 
of their Con-A-bound glycopeptides (Fig 1) . The latter material 
can, on the basis of its sugar composition [1], elution behavior 
on Sephadex G-50, and its binding to Con-A-Sepharose, tenta-
tively be characterized as "biantennary" glycopeptides 
[11,12]. H ence the observed differences between basal and 
differentiated cells are probably related to the sialic acid content 
of their biantennary glycoproteins (Table III). 
Tape stripping of normal skin resulted in an increased per-
centage of cells in S-phase, reaching a m aximum (comparable 
to figures found for psoriatic les ions ) around 48 111'. These 
results are comparable to earlier findings using tape stripping 
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[13] or after ultraviolet irradiation [14]. D ifferences, however, 
in molecular weigh t distribution and in affini ty to Con-A of 
fucose-labeled glycopeptides occur 24 hr after stripping com-
pared to normal. S ince t his is markedly earlier than th e peak 
for en tra nce to S-phase it is clear that the molecular changes 
are taking place in the G )-phase of the keratinocyte. 
Previously reported changes of the molecular weight com-
position of fucose-labeled glycopeptides from psoriatic unin-
volved skin [1] appear to be caused by differences in the Con-
A-unbound glycopeptides (Table III). Presumably, the more 
highly branched structures (triantennary and higher) are pre-
sent in reduced quantity in the fucosylated glycoproteins of 
psoriatic uninvolved epidermis compared to normal, in view of 
the results after neuraminidase treatment (Table III). 
The molecular weight distribution of fucose-labeled glyco-
peptides from psoriatic lesions, showing a relative increase in 
high-molecular-weigh t structures compared to normal [1], ap-
pears largely to be the consequence of an increased percentage 
of triantennary and higher-branched structures (Table II) . In 
addition, molecular weigh t distributions of Con-A-bound as 
well as Con-A-unbound glycopeptides from psoriatic lesions 
demonstrate that high-molecular-weight species ar e present to 
a greater exten t tha n in normal skin. In summary, the glyco-
peptide composition observed for psoriatic lesions cannot be 
explained in terms of a n increased growth fraction. This conclu-
sion is valid regardless of whether the increase results from an 
absolute increase in cycling cells, such as occurs during the 
regeneration response, or whether it is a consequence of a 
reduction in the proportion of differentiated cells in the overall 
population. The possibility that our previous findings are of 
direct pathogenic significance for psoriasis is thus considerably 
strengthened. 
We would like to thank Dr. F. W. Bauer for measurements of 
th e DNA con tent by flow cytometry a nd D r. P. D. Mier for 
helpful discussion of this manuscript. 
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An International Conferen ce on Cutan eous Oncology will be held at T he Hague, The N etherlands, September 
12-16, 1983. The format will include lectures, workshops, and seminars presen ted by an international faculty as well 
as free communications a nd poster sessions. For further information: R ichard L. Dobson, M.D. , Department of 
Dermatology, Medical University of South Carolina, Charleston, South Carolina 29425. 
The Annual Meeting of the British Society for Investigative Dermatology will take place at the University of 
Nottingha m on September 30 to October 1, 1983. The program will include sessions for both formal (oral) and poster 
communications. Abstracts should be submitted on the new official forms and must be received by July 8, 1983. For 
fur ther information: Dr. R A. J. Eady, Chairman, B.S.I.D., Institute of Dermatology, Homerton Grove, Lond on E9 
SBX. 
